Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Finished Drug Prices
NA
1. (1-hydroxy-2-(imidazo(1,2-a)-pyridin-3-yl)ethylidene)bisphosphonic Acid Monohydrate
2. 1-hydroxy-2-(imidazo(1,2-a)pyridin-3-yl)ethane-1,1-bisphosphonic Acid Monohydrate
3. Minodronate
4. Minodronic Acid Hydrate
5. Ono-5920
6. Phosphonic Acid, (1-hydroxy-2-imidazo(1,2-a)pyridin-3-ylethylidene)bis-
7. Yh 529
8. Yh-529
9. Yh529
10. Ym 529
11. Ym-529
12. Ym529
1. 155648-60-5
2. Minodronic Acid Hydrate
3. (1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-diyl)diphosphonic Acid Hydrate
4. Minodronic Acid Hydrate [jan]
5. Ym-529 (hydrate)
6. Minodronic Acid (hydrate)
7. 457x74v7nd
8. (1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic Acid;hydrate
9. Phosphonic Acid, (1-hydroxy-2-imidazo(1,2-a)pyridin-3-ylethylidene)bis-, Monohydrate
10. Phosphonic Acid, P,p'-(1-hydroxy-2-imidazo(1,2-a)pyridin-3-ylethylidene)bis-, Hydrate (1:1)
11. Minodronic Acid Hydrate (jan)
12. Phosphonic Acid, P,p'-(1-hydroxy-2-imidazo[1,2-a]pyridin-3-ylethylidene)bis-, Hydrate (1:1)
13. Minodronate Hydrate
14. Minodronate Monohydrate
15. Unii-457x74v7nd
16. Recalbon (tn)
17. Bonoteo (tn)
18. 127657-42-5
19. Schembl6009958
20. Dtxsid80165944
21. Bcp28470
22. Akos022186525
23. Minodronic Acid Monohydrate [mi]
24. Ac-25762
25. Ft-0689647
26. D09198
27. F78008
28. A848235
29. Q27258817
30. (1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-diyl)diphosphonicacidhydrate
31. (1-hydroxy-2-{imidazo[1,2-a]pyridin-3-yl}-1-phosphonoethyl)phosphonic Acid Hydrate
Molecular Weight | 340.16 g/mol |
---|---|
Molecular Formula | C9H14N2O8P2 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 4 |
Exact Mass | 340.02253940 g/mol |
Monoisotopic Mass | 340.02253940 g/mol |
Topological Polar Surface Area | 154 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 439 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Global Sales Information
Market Place
ABOUT THIS PAGE
A Minodronic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Minodronic Acid, including repackagers and relabelers. The FDA regulates Minodronic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Minodronic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Minodronic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Minodronic Acid supplier is an individual or a company that provides Minodronic Acid active pharmaceutical ingredient (API) or Minodronic Acid finished formulations upon request. The Minodronic Acid suppliers may include Minodronic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Minodronic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Minodronic Acid Drug Master File in Japan (Minodronic Acid JDMF) empowers Minodronic Acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Minodronic Acid JDMF during the approval evaluation for pharmaceutical products. At the time of Minodronic Acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Minodronic Acid suppliers with JDMF on PharmaCompass.
A Minodronic Acid written confirmation (Minodronic Acid WC) is an official document issued by a regulatory agency to a Minodronic Acid manufacturer, verifying that the manufacturing facility of a Minodronic Acid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Minodronic Acid APIs or Minodronic Acid finished pharmaceutical products to another nation, regulatory agencies frequently require a Minodronic Acid WC (written confirmation) as part of the regulatory process.
click here to find a list of Minodronic Acid suppliers with Written Confirmation (WC) on PharmaCompass.
Minodronic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Minodronic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Minodronic Acid GMP manufacturer or Minodronic Acid GMP API supplier for your needs.
A Minodronic Acid CoA (Certificate of Analysis) is a formal document that attests to Minodronic Acid's compliance with Minodronic Acid specifications and serves as a tool for batch-level quality control.
Minodronic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Minodronic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Minodronic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Minodronic Acid EP), Minodronic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Minodronic Acid USP).
LOOKING FOR A SUPPLIER?